AUD 0.8
(2.56%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 1.93 Million AUD | -12.63% |
2023 | 2.21 Million AUD | 17.44% |
2022 | 1.88 Million AUD | 210.59% |
2021 | 607.53 Thousand AUD | 52.39% |
2020 | 398.67 Thousand AUD | 141.12% |
2019 | 165.34 Thousand AUD | -33.18% |
2018 | 247.45 Thousand AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 FY | 1.93 Million AUD | -12.63% |
2024 Q4 | 838.18 Thousand AUD | 100.0% |
2024 Q3 | 419.09 Thousand AUD | -61.83% |
2024 Q1 | 548.91 Thousand AUD | -47.25% |
2024 Q2 | 1.09 Million AUD | 100.0% |
2023 Q4 | 1.04 Million AUD | 93.2% |
2023 Q2 | 1.17 Million AUD | 100.0% |
2023 FY | 2.21 Million AUD | 17.44% |
2023 Q1 | 587.64 Thousand AUD | -42.13% |
2023 Q3 | 538.61 Thousand AUD | -54.17% |
2022 Q2 | 871.4 Thousand AUD | 100.0% |
2022 Q1 | 435.7 Thousand AUD | 34.86% |
2022 FY | 1.88 Million AUD | 210.59% |
2022 Q4 | 1.01 Million AUD | 93.56% |
2022 Q3 | 524.63 Thousand AUD | -39.79% |
2021 Q4 | 323.08 Thousand AUD | 80.63% |
2021 FY | 607.53 Thousand AUD | 52.39% |
2021 Q3 | 178.86 Thousand AUD | -37.12% |
2021 Q2 | 284.45 Thousand AUD | 99.86% |
2021 Q1 | 142.32 Thousand AUD | -45.55% |
2020 FY | 398.67 Thousand AUD | 141.12% |
2020 Q2 | 137.29 Thousand AUD | 100.0% |
2020 Q4 | 261.37 Thousand AUD | 100.0% |
2020 Q3 | 130.68 Thousand AUD | -4.82% |
2020 Q1 | 68.65 Thousand AUD | 0.0% |
2019 FY | 165.34 Thousand AUD | -33.18% |
2018 FY | 247.45 Thousand AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Althea Group Holdings Limited | 29.4 Million AUD | 93.415% |
Cann Group Limited | 15.37 Million AUD | 87.406% |
ECS Botanics Holdings Ltd | 20.03 Million AUD | 90.335% |
Ecofibre Limited | 27.98 Million AUD | 93.082% |
Elixinol Wellness Limited | 8.26 Million AUD | 76.587% |
Hygrovest Limited | 260 Thousand AUD | -644.621% |
IDT Australia Limited | 13.22 Million AUD | 85.362% |
Invion Limited | 3.69 Million AUD | 47.594% |
Little Green Pharma Ltd | 19.56 Million AUD | 90.106% |
Medical Developments International Limited | 33.14 Million AUD | 94.16% |
Vitura Health Limited | 123.87 Million AUD | 98.437% |
Vita Life Sciences Limited | 74.16 Million AUD | 97.389% |